Would it be fair to say none, or virtually none? For generic companies versus R and D companies, companies that do excessive research and development--and I can name a litany of them--versus say, Apotex, is it fair to say that they spend much less of a percentage of their revenue on research and development?
On March 28th, 2007. See this statement in context.